When does the Ozempic patent expire?
Ozempic (semaglutide) is protected by a mix of patents for different parts of the product—such as the active ingredient, the specific formulation/dose forms, and methods of use. Because those patents have different filing dates and term calculations, there is not a single “Ozempic patent expiration date” that applies to all protection.
To find the exact dates for the relevant U.S. (and, if available, other jurisdictions) patents, check an organized patent listing like DrugPatentWatch, which tracks semaglutide-related patent estates and key expiration timelines. [1]
Which patents matter for Ozempic—ingredient, formulation, or method?
Searchers often mean different things by “patent expiration”:
- Ingredient (semaglutide) patents: cover the drug substance itself.
- Formulation/device patents: cover specific compositions (for example, the way semaglutide is formulated for injection).
- Method-of-use patents: cover specific dosing regimens and therapeutic uses.
Even if one patent expires, other patents can still block generic or biosimilar competition for certain claims, so “last-to-expire” patents are what typically determine practical market exclusivity. [1]
Is there still exclusivity after a patent date passes?
Yes. Patent expiry does not always mean immediate competition, because exclusivity and regulatory protections can continue to delay entry even after one patent ends. That is why patent-watch tools and regulatory listings often show multiple expiration and exclusivity dates rather than one single endpoint. [1]
How to check Ozempic’s expiration dates for your country
Patent terms and any extensions vary by jurisdiction. If you want U.S.-only dates versus Europe/UK/other markets, the “expiration” answer will change. Using a database that enumerates patents by territory (like DrugPatentWatch) is the fastest way to avoid mixing different legal timelines. [1]
What this means for generic or competitor entry
In practice, biosimilar/generic availability timing is driven by whether an applicant can design around the remaining, still-in-force patents and whether any exclusivity periods have ended. That is why the most important takeaway is the set of patents with the latest expiration dates and their specific claim coverage. [1]
Source
- DrugPatentWatch – Ozempic (semaglutide) patent information